144 related articles for article (PubMed ID: 12903403)
21. [Clinical and radiological features of gestational trophoblastic tumors].
Mamouni N; Boumhaoued S; Erraghay S; Boubou M; Bouchikhi C; Banani A
Pan Afr Med J; 2017; 28():228. PubMed ID: 29629014
[TBL] [Abstract][Full Text] [Related]
22. Expression pattern alterations of the serine protease HtrA1 in normal human placental tissues and in gestational trophoblastic diseases.
Marzioni D; Quaranta A; Lorenzi T; Morroni M; Crescimanno C; De Nictolis M; Toti P; Muzzonigro G; Baldi A; De Luca A; Castellucci M
Histol Histopathol; 2009 Oct; 24(10):1213-22. PubMed ID: 19688690
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of E-cadherin and integrin β-1 in trophoblasts is associated with malignant gestational trophoblastic diseases.
Shu H; Chen H; Yang B; Chang Z; Xiong M; Chen W
Int J Gynecol Cancer; 2013 May; 23(4):749-54. PubMed ID: 23455756
[TBL] [Abstract][Full Text] [Related]
24. [Gestational trophoblastic disease].
Allias F; Bolze PA; Gaillot-Durand L; Devouassoux-Shisheboran M;
Ann Pathol; 2014 Dec; 34(6):434-47. PubMed ID: 25499859
[TBL] [Abstract][Full Text] [Related]
25. Trophoblastic disease.
Ngan HY; Kohorn EI; Cole LA; Kurman RJ; Kim SJ; Lurain JR; Seckl MJ; Sasaki S; Soper JT
Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 2():S130-6. PubMed ID: 22999504
[No Abstract] [Full Text] [Related]
26. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
27. PHENOTYPIC CHARACTERISTICS OF CHORIONIC VILLI DURING GESTATIONAL TROPHOBLASTIC DISEASES.
Chikvaidze N; Kintraia N; Muzashvili T; Gachechiladze M; Burkadze G
Georgian Med News; 2019 Jan; (286):140-145. PubMed ID: 30829607
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of the proliferative marker Ki67 in hydatidiform moles and its diagnostic value in the progression to gestational trophoblastic neoplasia.
Hasanzadeh M; Sharifi N; Esmaieli H; Daloee MS; Tabari A
J Obstet Gynaecol Res; 2013 Feb; 39(2):572-7. PubMed ID: 22925155
[TBL] [Abstract][Full Text] [Related]
29. [Expression of R2 protein in gestational trophoblastic diseases].
Cui JQ; Shi YF; Zhou HJ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 33(5):433-6. PubMed ID: 15476328
[TBL] [Abstract][Full Text] [Related]
30. GATA3 expression in gestational trophoblastic tissues and tumours.
Mirkovic J; Elias K; Drapkin R; Barletta JA; Quade B; Hirsch MS
Histopathology; 2015 Nov; 67(5):636-44. PubMed ID: 25753145
[TBL] [Abstract][Full Text] [Related]
31. Expression of epidermal growth factor in gestational trophoblastic disease (GTD).
John M; Rajalekshmy TN; Nair MB; Augustine J; Schultz G; Nair MK; Balaram P
J Exp Clin Cancer Res; 1997 Jun; 16(2):129-34. PubMed ID: 9261736
[TBL] [Abstract][Full Text] [Related]
32. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
[TBL] [Abstract][Full Text] [Related]
33. P57kip2 immunohistochemical expression and ultrastructural findings of gestational trophoblastic disease and related disorders.
Soma H; Osawa H; Oguro T; Yoshihama I; Fujita K; Mineo S; Kudo M; Tanaka K; Akita M; Urabe S; Kudo Y
Med Mol Morphol; 2007 Jun; 40(2):95-102. PubMed ID: 17572845
[TBL] [Abstract][Full Text] [Related]
34. Can Ki67 and Caspase Predict Molar Progression?
Nagib RM; M A Zaki M; Wageh A; Abdelrazik M
Fetal Pediatr Pathol; 2019 Oct; 38(5):444-448. PubMed ID: 31038005
[No Abstract] [Full Text] [Related]
35. Recognising gestational trophoblastic disease.
Alhamdan D; Bignardi T; Condous G
Best Pract Res Clin Obstet Gynaecol; 2009 Aug; 23(4):565-73. PubMed ID: 19375983
[TBL] [Abstract][Full Text] [Related]
36. Histopathological and immunohistochemical features of early hydatidiform mole in relation to subsequent development of persistent gestational trophoblastic disease.
Petts G; Fisher RA; Short D; Lindsay I; Seckl MJ; Sebire NJ
J Reprod Med; 2014; 59(5-6):213-20. PubMed ID: 24937960
[TBL] [Abstract][Full Text] [Related]
37. [Invasive hydatiform mole in a postmenopausal woman].
de la Fouchardière A; Cassignol A; Benkiran L; Rudigoz RC; Gougeon A; Devouassoux-Shisheboran M
Ann Pathol; 2003 Oct; 23(5):443-6. PubMed ID: 14752389
[TBL] [Abstract][Full Text] [Related]
38. [Association of the novel hydatidiform mole-related gene F10 with the invasiveness of trophoblastic tumor].
Zhou J; Chen SL; Xing FQ; Pang ZJ; Li B; Zhou WQ; Fu X; Ding YQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):171-3. PubMed ID: 15698997
[TBL] [Abstract][Full Text] [Related]
39. Gestatational trophoblastic disease: multimodality imaging assessment with special emphasis on spectrum of abnormalities and value of imaging in staging and management of disease.
Kani KK; Lee JH; Dighe M; Moshiri M; Kolokythas O; Dubinsky T
Curr Probl Diagn Radiol; 2012; 41(1):1-10. PubMed ID: 22085657
[TBL] [Abstract][Full Text] [Related]
40. [Potential role of the angiogenic factor "EG-VEGF" in gestational trophoblastic diseases].
Boufettal H; Feige JJ; Benharouga M; Aboussaouira T; Nadifi S; Mahdaoui S; Samouh N; Alfaidy N
Pathol Biol (Paris); 2013 Oct; 61(5):178-83. PubMed ID: 23647696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
